Physikalische und biologische Halbwertzeit von radiochemisch reinem 59Fe / Physical and Biological Half-Life of Radiochemically Pure 59Fe

1971 ◽  
Vol 26 (1) ◽  
pp. 13-20 ◽  
Author(s):  
H. C. Heinrich ◽  
E. E. Gabbe ◽  
D. H. Whang

At delivery commercial 59Fe-preparations contain up to 1% contamination by 60Co, 65Zn, 54Mn, 46Sc, 134Cs, etc., so that the physical half-life of such preparations is not constant and starts to increase permanently after about 100 days. Anion exchange chromatography was used to prepare 59Fe with a radiochemical purity of ≧ 99.999999% as demonstrated by analytical anion exchange chromatography, paper- and thin-layer chromatography, and γ-spectroscopy. The physical half-life of radiochemically pure 59Fe was found to be constant over 500 days with 44.52 ± 0.016 days (λ= 0.015568 ± 0.0000056 [d-1]).The whole-body retention of radiochemically pure 59Fe was measured in man over one year with a 4 π-geometry whole-body radioactivity detector and utilized for the estimation of the effective half-life of 59Fe. The correct physical half-life of radiochemically pure 59Fe was used for the calculation of the biological half-life. Normal male subjects showed an effective half-life of 43.6 ± 0.34 days and a biological half-life of 2136 ± 807 days. This means a whole-body-59Fe-turnover rate of 0.032 ± 0.012%/d equivalent to 1.25 ± 0.46 mg Fe/d (for a whole-body iron pool of 3850 mg in a 70 kg man). Menstruating females were observed to have effective half-lives of 43.1 ± 0.22 days and therefore biological half-lives of 1389 ± 224 days. Their whole-body-59Fe-turnover rate is higher (than in males) with 0.050 ± 0.008%/d. For an optimal whole-body iron pool of 3300 mg (in 60 kg female) this would mean an iron loss of 1.65 ± 0.26 mg/d. Non-menstruating females were quite similar to males. They showed effective and biological 59Fe-half-lives of 43.5 ± 0.48 and 1833 ± 857 days, respectively. Their whole-body-59Fe-turnover rate was calculated to be 0.038 ± 0.018%/d or 1.25 ± 0.59 mg Fe/d (60 kg female with 3300 mg Fe-pool). These experimental data are the first direct and reliable proof for the magnitude of daily iron loss and iron requirements in man.

1964 ◽  
Vol 19 (11) ◽  
pp. 1032-1042 ◽  
Author(s):  
H. C. Heinrich ◽  
E. E. Gabbe

Chromatographically pure, vitamin B12-free 60CoCl2 as well as 60Co-vitamin B12 (60Co-cyanocobalamin and 60Co-aquocobalamin) and 60Co-vitamin B12-coenzyme (60Co-5.6-dimethylbenzimidazol-C5′-deoxyadenosyl-cobamid) were given orally and by injection in smallest amounts (10 — 100 pMol = 0.59-5.9 ng Co2®, 100 pMol = 136 ng vitamin B12 and 100 pMol = 158 ng vitamin B12-coenzyme) to female Sprague-Dawley rats.The whole body retention and excretion of the 60Co label was measured in a large volume radioactivity detector with liquid organic scintillators and 4 π-geometry. The biological half life and whole body metabolic turnover rate were calculated for the inorganic and organic cobalt from the kinetics of the 60Co whole body retention.After oral application of 100 pMol 60Co2® nearly all the 60Co is excreted already after 2 days within the faeces (90%), and the urine (15%). Only about 0.9% of the 60Co2⊕ leaves the rats with a biological half life of 18 days. After intramuscular injection of 100 pMol 60Co2⊕ about 91% of the 60Co are excreted in the urine and 10% in the faeces within four weeks. Only 4.6% of the 60Co2⊕ were eliminated with a biological half life of 28 days. The intramuscular injection of only 10 pMol 60Co2⊕ resulted in a faecal excretion of 82%, and an urinary excretion of 21% of the 60Co. A biological half life of 23 days was calculated for 8.6% of the 60Co2⊕. Inorganic cobalt is therefore practically not retained in the body and rapidly excreted mainly with the urine after injection and mainly within the faeces after oral uptake.In contrast to the inorganic cobalt a completely different metabolic behaviour is typical for the cobalt, which is incorporated in the organic structure of the vitamin B12- and vitamin B12-coenzyme molecules. This organic cobalt accumulates in the storage organs and tissues (kidney, liver etc.) after absorption as well as after injection of 100 pMol 60Co-vitamin B12 and 60Co-vitamin B12coenzyme. Only 15% of the 60Co-cyanocobalamin and 9—10% of the 60Co-aquocobalamin and 60°Covitamin B12-coenzyme are excreted within 48 hours after injection. The organ and tissue incorporated 60Co-vitamin B12 and 60Co-vitamin B12-coenzyme is metabolized with a biological half life of about 52 days. From the whole body pool size of 20 μg vitamin B12 and the biological half life a metabolic turnover rate of 0.27 μg vitamin B12/day or 1.34% of the vitamin-B12-pool per days was calculated for the whole body of the rat.The lacking organ and tissue retention of absorbed and injected 60Co2⊕ and its short biological half life in rats (if compared with the organic cobalt in the vitamin B12-structure) as well as the comparison of the total cobalt content of human liver (measured by physical techniques) with the cobalt content calculated from the vitamin B12-content of human liver (measured by microbiological assay) do not support a biological significance and function of inorganic cobalt in mammals. There is no evidence at the moment that any cobalt besides the cobalt in the vitamin B12 and vitamin B12-coenzymes is existing and biochemically active in humans or animals.


Author(s):  
Joao Carlos Simoes-Cardoso ◽  
Nanako Hoshino ◽  
Yusuke Yoshimura ◽  
Chyi-Shin Chen ◽  
Cristina Dias-Cabral ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document